中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共527条，第1-10条 帮助

条数/页： 排序方式：
Discovery of novel SOS1 inhibitors using machine learning 期刊论文  OAI收割
RSC MEDICINAL CHEMISTRY, 2024, 卷号: 15, 期号: 4, 页码: 1392-1403
作者:  Duo, Lihui;  Chen, Yi;  Liu, Qiupei;  Ma, Zhangyi;  Farjudian, Amin
  |  收藏  |  浏览/下载：1/0  |  提交时间：2024/05/07
D3EGFR: a webserver for deep learning-guided drug sensitivity prediction and drug response information retrieval for EGFR mutation-driven lung cancer 期刊论文  OAI收割
BRIEFINGS IN BIOINFORMATICS, 2024, 卷号: 25, 期号: 3, 页码: 10
作者:  Shi, Yulong;  Li, Chongwu;  Zhang, Xinben;  Peng, Cheng;  Sun, Peng
  |  收藏  |  浏览/下载：31/0  |  提交时间：2024/05/07
JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers 期刊论文  OAI收割
CANCER LETTERS, 2024, 卷号: 582, 页码: 15
作者:  Lu, Xuxiu;  Yu, Rilei;  Li, Zhen;  Yang, Mengke;  Dai, Jiajia
  |  收藏  |  浏览/下载：16/0  |  提交时间：2024/04/07
SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10
作者:  Li, Wen-jing;  Xie, Cheng-ying;  Zhu, Xi;  Tang, Jiao;  Wang, Lei
  |  收藏  |  浏览/下载：35/0  |  提交时间：2024/02/19
Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12
作者:  Lin, Ting-ting;  Xiong, Wei;  Chen, Gui-hua;  He, Yang;  Long, Li
  |  收藏  |  浏览/下载：9/0  |  提交时间：2024/01/26
Synthesis, and biological evaluation of EGFR/HER2-NAMPT conjugates for tumor treatment 期刊论文  OAI收割
MOLECULAR DIVERSITY, 2023, 页码: 20
作者:  Ding, Mengyuan;  Shen, Qianqian;  Lu, Wei;  Zhu, Shulei
  |  收藏  |  浏览/下载：92/0  |  提交时间：2023/10/17
Peptide-functionalized therapeutic nanoplatform for treatment orthotopic triple negative breast cancer and bone metastasis 期刊论文  OAI收割
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2023, 卷号: 50, 页码: 102669
作者:  Li, Daifeng;  Ma, Shengnan;  Xu, Denghui;  Meng, Xiaocao;  Lei, Ningjing
  |  收藏  |  浏览/下载：6/0  |  提交时间：2024/03/27
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer 期刊论文  OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 13
作者:  Zhou, Ji;  Zhang, Xu-Chao;  Xue, Shan;  Dai, Mengdi;  Wang, Yueliang
  |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17
Design, Synthesis, and Evaluation of (R)-8-((Tetrahydrofuran-2-yl)methyl)pyrido[2,3-d]pyrimidin-7-ones as Novel Selective ACK1 Inhibitors to Combat Acquired Resistance to the Third-Generation EGFR Inhibitor 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 页码: 17
作者:  Li, Qian;  Zhang, Tao;  Song, Peiran;  Tong, Linjiang;  Feng, Fang
  |  收藏  |  浏览/下载：20/0  |  提交时间：2023/10/17
Anxiolytic-like effect of Suanzaoren-Wuweizi herb-pair and evidence for the involvement of the monoaminergic system in mice based on network pharmacology 期刊论文  OAI收割
BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 卷号: 23, 期号: 1, 页码: 17
作者:  Liu, Jie;  Shi, Jin-Li;  Guo, Jian-You;  Chen, Yi;  Ma, Xiao-Jie
  |  收藏  |  浏览/下载：42/0  |  提交时间：2023/03/01